InMode (INMD) Cash from Financing Activities (2018 - 2026)
InMode's (INMD) quarterly Cash from Financing Activities came in at -$32.4 million in Q1 2026, up 67.4% year-on-year from -$19.4 million in Q1 2025, and down 23768.61% quarter-over-quarter from $137000.0 in Q4 2025.
InMode (INMD) Cash from Financing Activities (2018 - 2026) Analysis & Trends
InMode has disclosed Cash from Financing Activities across 9 years of filings, most recently posting -$32.4 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$32.4 million, up 67.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$59.0 million (up 84.57% YoY), and the FY2025 annual result was -$126.1 million, up 55.42% from the prior year.
- Cash from Financing Activities came in at -$32.4 million for Q1 2026 at InMode, down from $137000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.7 million in Q3 2023 to a low of -$118.4 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is $204000.0 (2022), against an average of -$28.0 million.
- Across the five-year window, Cash from Financing Activities soared 396.18% in 2023 and plunged 43165.09% in 2024, its largest moves.
- InMode's Cash from Financing Activities stood at $637000.0 in 2022, then slumped by 56.83% to $275000.0 in 2023, then slumped by 43165.09% to -$118.4 million in 2024, then jumped by 100.12% to $137000.0 in 2025, then slumped by 23768.61% to -$32.4 million in 2026.
- The last three Cash from Financing Activities figures came in at -$32.4 million (Q1 2026), $137000.0 (Q4 2025), and $249000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | InMode | 3.35 | -388.37 Mn | 61.55 Mn | -32.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.43 Mn |
| Mar 31, 2026 | -32.43 Mn |
| Dec 31, 2025 | 137,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | -26.98 Mn |
| Jun 30, 2025 | -26.98 Mn |
| Mar 31, 2025 | -99.47 Mn |
| Mar 31, 2025 | -99.47 Mn |
| Dec 31, 2024 | -118.43 Mn |
| Dec 31, 2024 | -118.43 Mn |
| Sep 30, 2024 | -75.99 Mn |
| Sep 30, 2024 | -75.99 Mn |
| Jun 30, 2024 | -88.59 Mn |
| Jun 30, 2024 | -88.59 Mn |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Dec 31, 2023 | 275,000.00 |